Neuroprotective Effects of Hydroxysafflor Yellow A: In Vivo and in Vitro Studies

 

 Buy Article Permissions and Reprints

Abstract

Previous work has shown that hydroxysafflor yellow A (HSYA), extracted from Carthamus tinctorius L. markedly extended the coagulation time in mice and exhibited a significant antithrombotic effect in rats. The present study was conducted to demonstrate further its neuroprotective effects on cerebral ischemic injury in both in vivo and in vitro studies. In vivo, male Wistar-Kyoto (WKY) rats with middle cerebral artery occlusion (MCAO) were evaluated for neurological deficit scores followed by the treatment with a single dose of HSYA. Furthermore, the infarction area of the brain was assessed in the brain slices. In vitro, the effect of HSYA was tested in cultured fetal cortical cells exposed to glutamate and sodium cyanide (NaCN) to identify its neuroprotection against neurons damage. The results in vivo showed that sublingular vein injection of HSYA at doses of 3.0 mg/kg and 6.0 mg/kg exerted significant neuroprotective effects on rats with focal cerebral ischemic injury by significantly decreasing neurological deficit scores and reducing the infarct area compared with the saline group, HSYA at a dose of 6.0 mg/kg showed a similar potency as nimodipine at a dose of 0.2 mg/kg. Sublingular vein injection of HSYA at the dose of 1.5 mg/kg showed a neuroprotective effect, however, with no significant difference when compared with the saline group. Results in vitro showed that HSYA significantly inhibited neuron damage induced by exposure to glutamate and sodium cyanide (NaCN) in cultured fetal cortical cells. Noticeably, the neuroprotective action of HSYA on glutamate-mediated neuron injury was much better than that of HSYA on NaCN-induced neuron damage. All these findings suggest that HSYA might act as a potential neuroprotective agent useful in the treatment in focal cerebral ischemia.

Abbreviations

HSYA:hydroxysafflor yellow A

TTC:2,3,5-triphenyltetrazolium chloride

MTT:3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide

DMEM:Dulbecco's modified Eagle medium

FCS:Fetal calf serum

MCAO:middle cerebral artery occlusion

ECA:external carotid artery

ICA:internal carotid artery

LDH:lactate dehydrogenase

NMDA:N-methyl-D-aspartate

References

• 1 Kohei K, Takashi T, Katusura S, Hisatomo T, Takeshi M, Toshikatsu M. Ouinochalcones and flavonoids from fresh florets in different cultivars of Carthamus tinctorius L.  Bioscience Biotechnology and Biochemistry. 2000;  64 1588-99
  CrossrefPubMedGoogle Scholar
• 2 Romano C, Price M, Bai H Y, Olney J W. Neuroprotectants in Honghua: glucose attenuates retinal ischemic damage.  Investigative Ophthalmology Visual Science. 1993;  34 72-80
  PubMedGoogle Scholar
• 3 Zea Longa E. Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats.  Stroke. 1989;  20 84-91
  CrossrefPubMedGoogle Scholar
• 4 De Cristobal J, Moro M A, Davalos A, Castillo J, Leza J C, Camarero J, Colado M I, Lorenzo P, Lizasoain I. Neuroprotective effect of aspirin by inhibition of glutamate release after permanent focal cerebral ischemia in rats.  Journal of Neurochemistry. 2001;  79 456-9
  CrossrefPubMedGoogle Scholar
• 5 Van Dorsten F A, Olah L, Schwindt W, Grune M, Uhlenkuken U, Pillekamp F, Hos H SY, Ann K A, Hoehn M. Dynamic changes of ADC, perfusion, and NMR relaxation parameters in transient focal ischemia of rat brain.  Magnetic Resonance in Medicine. 2002;  47 97-104
  CrossrefPubMedGoogle Scholar
• 6 Nishizawa Y. Glutamate release and neuronal damage in ischemia.  Life Science. 2001;  69 369-81
  CrossrefPubMedGoogle Scholar
• 7 Meselha M R, Kadota S, Momose Y, Hatakeyama N, Kusai A, Hattori M, Namba T. Two new quinochalcone yellow pigments from Carthamus tinctorius and Ca²⁺ antagonistic activity of tinctormine.  Chemistry Pharmacetics Bulletin. 1993;  41 1796-802
  PubMedGoogle Scholar
• 8 Takei N, Kondo J, Nagaike K, Ohaswa K, Kato K, Kohsaka S. Neuronal survival factor from bovine brain is identical to neuron-specific enolase.  Journal of Neurochemistry. 1991;  57 1178-84
  PubMedGoogle Scholar
• 9 Ferrari M, Fornasiero M C, Isetta A M. MTT colorimetric assay for testing macrophage cytotoxic activity in vitro .  Journal of Immunological Methods. 1990;  131 165-72
  CrossrefPubMedGoogle Scholar
• 10 Zornow M H, Prough D S. Neuroprotective properties of calcium-channel blockers.  New Horizons - the Science and Practice of Acute Medicine. 1996;  4 107-14
  PubMedGoogle Scholar
• 11 Horn J, de Haan R J, Vermeulen M, Luiten P G, Limburg M. Nimodipine in animal model experiments of focal cerebral ischemia: a systematic review.  Stroke. 2001;  32 2433-8
  CrossrefPubMedGoogle Scholar
• 12 Pennypacker K R, Hernandez H, Benkovic S, Morgan D G, Willing A E, Sanberg P R. Induction of presenilins in the rat brain after middle cerebral arterial occlusion.  Brain Research Bulletin. 1999;  48 539-43
  CrossrefPubMedGoogle Scholar
• 13 Kimura M, Sawada K, Miyagawa T, Kuwada M, Katayama K, Nishizawa Y. Role of glutamate receptors and voltage-dependent calcium and sodium channels in the extracellular glutamate/aspartate accumulation and subsequent neuronal injury induced by oxygen/glucose deprivation in cultured hippocampal neurons.  Journal of Pharmacology and Experimental Therapeutics. 1998;  285 178-85
  PubMedGoogle Scholar
• 14 McCulloch J, Ozyurt E, Park C K, Nehls D G, Teasdale G M, Graham D I. Glutamate receptor antagonists in experimental focal cerebral ischaemia.  Acta Neurochirurgica (Supplement). 1993;  57 73-9
  PubMedGoogle Scholar
• 15 Ding Q L, Zhang G, Liu G Q, Huang W L. Effects of E6, a calmodulin antagonist on ischemic injury in cultural pheochromocytoma (PC₁₂) cells and rat primary cortical neurons.  Journal of Chinese Pharmacology. 1999;  34 742-5
  PubMedGoogle Scholar

Prof. Dr. Ke Liu

School of Pharmacy of Yantai University

No 32, Qingquan Road

Laishan District

Yantai

Shangdong 264003

P. R. China

Phone: +86-535-6713858

Fax: +86-535-6713858

Email: Liuke @luye-pharm.com